No Data
Gale Pharmaceutical Group-B (01672.HK) spent 0.0236 million Hong Kong dollars on December 4 to repurchase 0.014 million shares.
On December 4, Gelonghui reported that GC Pharma-B (01672.HK) announced the repurchase of 0.014 million shares for a cost of 0.0236 million Hong Kong dollars.
China Grand Pharmaceutical and Healthcare Holdings Limited (01672.HK) spent 0.287 million Hong Kong dollars to repurchase 0.171 million shares on December 3.
Gracebond reported on December 3rd that Geely Pharmaceutical-B (01672.HK) announced a buyback of 0.171 million shares, costing 0.287 million Hong Kong dollars on December 3rd.
On December 2, 2023, Enhance Technology-B (01672) spent approximately 0.8116 million Hong Kong dollars to repurchase 0.5 million shares.
Abogen Pharmaceuticals-B (01672) announced that on December 2, 2024, it spent approximately 0.8116 million Hong Kong dollars to repurchase 50...
China Grand Pharmaceutical and Healthcare Holdings Limited (01672.HK) spent 0.993 million Hong Kong dollars to repurchase 0.6 million shares on November 27th.
GLEAM Pharmaceuticals-B (01672.HK) announced on November 27th that it spent 0.993 million Hong Kong dollars to repurchase 0.6 million shares.
On November 26, 2023, Kereon Pharmaceuticals-B (01672.HK) spent 0.336 million Hong Kong dollars to repurchase 0.2 million shares.
On November 26, Gelesis Pharmaceuticals-B (01672.HK) announced that it spent 0.336 million Hong Kong dollars to repurchase 0.2 million shares on November 26.
China Resources Pharmaceutical Group Limited -B(01672.HK) spent 0.513 million Hong Kong dollars to repurchase 0.3 million shares on November 25th.
On November 25, GeLi Pharmaceutical-B (01672.HK) announced that it repurchased 0.3 million shares for 0.513 million Hong Kong dollars on November 25th.
No Data
No Data
